Menu
21/08/2006
Ruling on bowel cancer drug attacked
A ruling that will refuse treatment on the NHS with two bowel cancer drugs has been attacked by both cancer patients and charities.
The government health treatment watchdog, the National Institute for Health and Clinical Excellence, has determined that Avastin and Erbitux are not recommended for the treatment of patients with metastatic bowel cancer.
However, Nice recommended that people being treated with the drugs should "have the option to continue therapy until they or their consultants consider it appropriate to stop." More prevalent in older people, bowel cancer is the third most common cancer in the UK, and accounts for 12-14% of cancers.
The overall survival rate is around five years, and charities claim that research has shown that the drugs help to extend life by up to five months.
Charities branded the decision by Nice as further evidence that those living with bowel cancer were not being given the attention or funding that they deserved.
Used after front line treatments such as chemotherapy have failed, both treatments are relatively costly. Avastin costing around £18,000 and Erbitux almost £12,000 per patient.
Nice said that neither represented efficient use of scarce NHS resources.
Nice claims that there was insufficient evidence to recommend the treatments for patients whose cancer had spread to other parts of the body.
Both monoclonal antibody treatments, Avastin, also known as bevacizumab, helps by reducing the blood supply to cancerous tumours and reducing their growth and Erbitux, known as cetuximab, helps to block the spread of cancer cells.
(SP)
The government health treatment watchdog, the National Institute for Health and Clinical Excellence, has determined that Avastin and Erbitux are not recommended for the treatment of patients with metastatic bowel cancer.
However, Nice recommended that people being treated with the drugs should "have the option to continue therapy until they or their consultants consider it appropriate to stop." More prevalent in older people, bowel cancer is the third most common cancer in the UK, and accounts for 12-14% of cancers.
The overall survival rate is around five years, and charities claim that research has shown that the drugs help to extend life by up to five months.
Charities branded the decision by Nice as further evidence that those living with bowel cancer were not being given the attention or funding that they deserved.
Used after front line treatments such as chemotherapy have failed, both treatments are relatively costly. Avastin costing around £18,000 and Erbitux almost £12,000 per patient.
Nice said that neither represented efficient use of scarce NHS resources.
Nice claims that there was insufficient evidence to recommend the treatments for patients whose cancer had spread to other parts of the body.
Both monoclonal antibody treatments, Avastin, also known as bevacizumab, helps by reducing the blood supply to cancerous tumours and reducing their growth and Erbitux, known as cetuximab, helps to block the spread of cancer cells.
(SP)
Related UK National News Stories
Click here for the latest headlines.
24 July 2007
Cancer test kit 'could lead to 20,000 fewer deaths'
Deaths from bowel cancer could be dramatically reduced if people use a self-testing kit being sent to people in their sixties throughout the country, a cancer charity has predicted.
Cancer test kit 'could lead to 20,000 fewer deaths'
Deaths from bowel cancer could be dramatically reduced if people use a self-testing kit being sent to people in their sixties throughout the country, a cancer charity has predicted.
04 April 2013
Uncertainty Over Cancer Care Fund
Cancer charities have warned that thousands of cancer patients face uncertainty over future access to life-extending drugs when a cash pot ends next year. The £200m-a-year Cancer Drugs Fund allows patients in England to access drugs approved by their doctors, but which have not been cleared for widespread use on the NHS.
Uncertainty Over Cancer Care Fund
Cancer charities have warned that thousands of cancer patients face uncertainty over future access to life-extending drugs when a cash pot ends next year. The £200m-a-year Cancer Drugs Fund allows patients in England to access drugs approved by their doctors, but which have not been cleared for widespread use on the NHS.
22 September 2010
'Early Alert' Sounded Over Cancer
A new campaign that will alert people to the early signs of cancer and encourage them to get checked out will be launched in January next year. Care Services Minister Paul Burstow announced yesterday that the campaign would consist of 59 local campaigns focussing on the three big killers - breast, bowel and lung cancer.
'Early Alert' Sounded Over Cancer
A new campaign that will alert people to the early signs of cancer and encourage them to get checked out will be launched in January next year. Care Services Minister Paul Burstow announced yesterday that the campaign would consist of 59 local campaigns focussing on the three big killers - breast, bowel and lung cancer.
12 September 2011
Bowel Cancer Death Rates Must Not Be Ignored Warns Charity
Figures issued today by Beating Bowel Cancer reveal that bowel cancer death rates vary significantly across the UK, depending on where you live. These latest statistics released by the charity show that there is a three-fold variation in bowel cancer death rates between the best and worst performing areas across the UK.
Bowel Cancer Death Rates Must Not Be Ignored Warns Charity
Figures issued today by Beating Bowel Cancer reveal that bowel cancer death rates vary significantly across the UK, depending on where you live. These latest statistics released by the charity show that there is a three-fold variation in bowel cancer death rates between the best and worst performing areas across the UK.
27 October 2010
Lifestyle Tips Could Prevent Bowel Cancer Cases
A new study, published today by the British Medical Association, reveals that almost a quarter of colorectal (bowel) cancer cases could be prevented if people followed healthy lifestyle advice in five areas including diet and exercise.
Lifestyle Tips Could Prevent Bowel Cancer Cases
A new study, published today by the British Medical Association, reveals that almost a quarter of colorectal (bowel) cancer cases could be prevented if people followed healthy lifestyle advice in five areas including diet and exercise.
-
Northern Ireland WeatherThis Evening and Tonight:Showers, scattered in the evening, will clear by midnight leaving the night dry with clear spells. Perhaps a touch of ground frost. Cloud will spread east towards morning. Minimum temperature 2 °C.
